Effects of enalapril on inflammation in kidney of diabetic rats and its possible mechanism

Hao Qian,Yong-gui WU,Hui LIN,Min ZHAO,Dian ZHOU,Wen LU,Bo-ke ZHANG
DOI: https://doi.org/10.3321/j.issn:1000-4718.2005.05.026
2005-01-01
Abstract:AIM: To investigate the effects and mechanism of enalapril on nephritis of diabetic mice. METHODS: Diabetes was induced by injection of streptozotocin after uninephrectomy. Rats were randomly divided into three groups: control, diabetes, diabetes treated with enalapril (10 mg·kg~-1 ·d~-1 by gavage). 8 weeks after STZ injection, urine albumin excretion rate (AER) were measured, and glomerular morphology were observed by light microscopy. The levels of malonyldialdehyde (MDA) in renal tissue and urine as well as activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-PX) in renal tissue were determined. Immunohistochemistry for ED-1 (macrophage marker), monocyte chemoattractant protein-1 (MCP-1) and intercellular adhesion molecule-1 (ICAM-1) were performed by streptavidin-biotin complex (SABC) technique. RESULTS: Increased kidney weight, ratio of kidney weight to body weight, AER and expansion of mesangial as well as tuft areas on histological examination of the kidney were significantly attenuated by the treatment of enalapril (P0.05, P0.01). Elevated MDA levels in renal tissue and urine as well as decreased SOD, CAT, GSH-PX activities in renal tissue were also remitted by enalapril (P0.05). Increased glomerular macrophage recruitment and expression of MCP-1 was significantly inhibited by enalapril (P0.05). However, elevated ICAM-1 expression was not reduced by enalapril in glomerulus in diabetic rats. CONCLUSION: Possible mechanism of renal protection of enalapril may be at least partly related with suppression of inflammation in kidney of diabetic rats.
What problem does this paper attempt to address?